


Ask a doctor about a prescription for ESOMEPRAZOL DEMO 40 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION
Package Leaflet: Information for the User
Esomeprazol Demo 40mg Powder for Solution for Injection and Infusion EFG
esomeprazol
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Contents of the pack and further information
Esomeprazol Demo contains a medicine called esomeprazol, which belongs to a group of medicines called proton pump inhibitors. These work by reducing the amount of acid produced by the stomach.
Esomeprazol Demo is used for the short-term treatment of certain disorders, when oral treatment is not possible. It is used to treat the following disorders:
Adults
Children and adolescents from 1 to 18 years
Esomeprazol Demo should not be given to you:
If you are in any of these situations, you should not use Esomeprazol Demo. If you are not sure, talk to your doctor or nurse before you are given this medicine.
Warnings and precautions
Talk to your doctor or nurse before you start using Esomeprazol Demo if:
Esomeprazol may mask the symptoms of other diseases. Therefore, if you notice any of the following events before you are given Esomeprazol or after you are given it, contact your doctor immediately:
Taking a proton pump inhibitor like Esomeprazol Demo, especially for more than one year, may slightly increase the risk of hip, wrist, or spine fractures. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
Skin rashes and skin symptoms
If you get a skin rash, especially in areas of the skin exposed to the sun, talk to your doctor as soon as possible, as you may need to stop treatment with Esomeprazol Demo. Remember to mention any other symptoms that you notice, such as joint pain.
Severe skin rashes have occurred in patients taking esomeprazol (see also section 4). The rash can include ulcers in the mouth, throat, nose, genitals, and conjunctivitis (red and swollen eyes). These severe skin rashes often appear after symptoms similar to those of the flu, such as fever, headache, and body pain. The rash can cover large areas of the body with blisters and peeling skin.
If at any time during treatment (even after several weeks) you develop a rash or any of these skin symptoms, stop taking this medicine and contact your doctor immediately.
Using Esomeprazol Demo with other medicines
Tell your doctor or nurse if you are using, have recently used, or might use any other medicines, including those obtained without a prescription. This is because Esomeprazol can affect how some medicines work and some medicines can affect the effect of Esomeprazol.
Do not use Esomeprazol if you are taking a medicine that contains nelfinavir (used to treat HIV infection).
Tell your doctor or nurse if you are taking any of the following medicines:
Pregnancy, breastfeeding, and fertility
If you are pregnant, think you may be pregnant, or plan to become pregnant, talk to your doctor, pharmacist, or nurse before using this medicine. Your doctor will decide if you can take Esomeprazol during this period.
It is not known if Esomeprazol passes into breast milk. Therefore, you should not take Esomeprazol during breastfeeding.
Driving and using machines
Esomeprazol is unlikely to affect your ability to drive or use tools or machines.
However, rare adverse reactions such as dizziness or blurred vision (see section 4) can occur. If they do, patients should not drive or use machines.
Esomeprazol Demo contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per vial; this is essentially "sodium-free".
Esomeprazol Demo can be given to children and adolescents from 1 to 18 years and to adults, including elderly patients.
Administration of Esomeprazol Demo
Use in adults
Use in children and adolescents
If you are given too much Esomeprazol Demo
If you think you have been given too much Esomeprazol Demo, talk to your doctor immediately.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you notice any of the following serious side effects, stop taking Esomeprazol Demo and contact a doctor immediately:
Other side effects include:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from the available data)
In very rare cases, Esomeprazol Demo can affect the white blood cells, leading to immune system deficiency. If you have an infection with symptoms such as fever with a severe worsening of your general conditionor fever with symptoms of a local infection such as pain in the neck, throat, mouth, or difficulty urinating, you should see your doctor as soon as possible to rule out a decrease in the number of white blood cells (agranulocytosis) with a blood test. It is important that you inform your doctor about your medication.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly to the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Shelf life after reconstitution
Chemical and physical stability has been demonstrated for 12 hours at (30 ± 2)°C. From a microbiological point of view, the product should be used immediately.
Store below 30°C.
Esomeprazol Demo Composition
Product Appearance and Container Contents
Esomeprazol Demo is a porous cake or white to off-white powder. Before administration, it is reconstituted into a solution.
Presentation: 1, 5, 10, 20 vials. Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
DEMO S.A., PHARMACEUTICAL INDUSTRY, 21st km National Road Athens-Lamia, 14568 Krioneri, Attiki, Greece
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Germany: | Esomeprazole DEMO 40 mg Powder for solution for injection and infusion |
Greece: | DEMOLOX 40 mg Πούδρα για ενδομυϊκό διαλύμα και διαλύμα προς έγχυση |
Spain: | Esomeprazol Demo 40mg Powder for solution for injection and infusion EFG |
Cyprus: | DEMOLOX 40 mg Πούδρα για ενδομυϊκό διαλύμα και διαλύμα προς έγχυση |
The Netherlands: | Esomeprazol DEMO 40 mg poeder voor oplossing voor injectie/infusie |
Date of Last Revision of this Leaflet:12/2023.
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products http://www.aemps.es
This information is intended only for healthcare professionals:
Esomeprazol DEMO 40 mg contains 40 mg of esomeprazol, as sodium salt. Each vial also contains disodium edetate and sodium hydroxide (<1 mmol of sodium).
The vials are for single use. If the entire contents of the reconstituted vial are not used for a single dose, the unused solution must be discarded.
For more information on dosage recommendations and storage conditions, see the following sections
Preparation and Administration of the Reconstituted Solution:
The reconstituted solution for injection or infusion must be clear and colorless to slightly yellow. The reconstituted solution must be visually inspected for particles and discoloration before administration. Only the clear solution should be used.
Chemical and physical stability has been demonstrated for 12 hours at 30 ± 2°C. From a microbiological point of view, the product must be used immediately.
Esomeprazol Demo Injection
To prepare an injection solution:
40 mg Injection
For an injection solution (8 mg/ml), prepare the solution by adding 5 ml of sodium chloride 0.9% for intravenous use to the vial of esomeprazol 40 mg.
The reconstituted solution for injection must be administered intravenously over a period of at least 3 minutes.
For more information on dose administration, please see the technical sheet, section 4.2.
Esomeprazol Demo Infusion
To prepare an infusion solution:
40 mg Infusion
For an infusion solution, dissolve the contents of one vial of esomeprazol 40 mg in up to 100 ml of sodium chloride 0.9% for intravenous use.
80 mg Infusion
For an infusion solution, dissolve the contents of two vials of esomeprazol 40 mg in up to 100 ml of sodium chloride 0.9% for intravenous use.
For more information on dose administration, please consult the technical sheet, section 4.2.
Disposal
Any remaining medicinal product or waste material must be disposed of in accordance with local procedures.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ESOMEPRAZOL DEMO 40 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION – subject to medical assessment and local rules.